API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-13-2024-4844.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-28-2024-59068.pdf
https://www.globenewswire.com//news-release/2023/10/16/2760615/30757/en/Dar%C3%A9-Bioscience-Announces-Achievement-of-First-Commercial-Milestone-Under-License-Agreement-for-XACIATO-Clindamycin-Phosphate-Vaginal-Gel-2-FDA-Approved-Treatment-for-Bacterial-Vag.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-6-2023-36272.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214401
https://www.businesswire.com/news/home/20220811005562/en/Amneal-launches-4-new-Generic-products-including-Vasopressin-single-dose
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214668
https://www.globenewswire.com/news-release/2022/06/30/2472080/30757/en/Dar%C3%A9-Bioscience-Announces-Closing-of-Global-License-Agreement-with-Organon-to-Commercialize-XACIATO-clindamycin-phosphate-vaginal-gel-2-FDA-Approved-Treatment-for-Females-12-and-Ol.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212845
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215607
https://www.globenewswire.com/news-release/2021/12/07/2347833/30757/en/Dar%C3%A9-Announces-FDA-Approval-of-XACIATO-clindamycin-phosphate-Vaginal-Gel-as-a-Treatment-for-Bacterial-Vaginosis.html
https://www.globenewswire.com/news-release/2021/08/23/2284805/0/en/Solaris-Pharma-Receives-Approval-for-First-Generic-Version-of-Clindagel-clindamycin-phosphate-EQ-1.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212438
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214251
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-gets-usfda-nod-for-acne-treatment-drug/articleshow/80833080.cms
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214052
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211872
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210004
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209610
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205397
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207194
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206575
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210778
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-10-2019-1554872020.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209914
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210794
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207194
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208757
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208767
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208776
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-28-2018-1519803579.pdf
https://www.prnewswire.com/news-releases/perrigo-announces-tentative-fda-approval-for-the-generic-version-of-onexton-gel-300588900.html
https://www.prnewswire.com/news-releases/perrigo-announces-patent-litigation-settlement-for-the-generic-version-of-onexton-gel-300543948.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204748
http://www.prnewswire.com/news-releases/perrigo-announces-tentative-fda-approval-for-the-generic-version-of-acanya-gel-300521093.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-12-2017-1499837241.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208084
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204087
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-22-2017-1490161550.pdf
http://www.fiercepharma.com/manufacturing/perrigo-recalling-162-000-tubes-acne-gel
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206945
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208683
http://www.reuters.com/article/2015/11/12/valeant-pharmacies-officers-idUSL1N13706P20151112#oiVQh9Bs7fswguHF.97
https://www.pharmacompass.com/pdf/news/perrigos-generic-clindamycin-phosphate-and-benzoyl-peroxide-approved-in-us-for-acne-1443095021.pdf
http://www.prnewswire.com/news-releases/perrigo-announces-fda-approval-and-launch-of-the-ab-rated-generic-version-of-benzaclin-topical-gel-300146992.html
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/202564Orig1s000ltr.pdf